yes
Location: United States, Massachusetts, Lexington
Employees: 11-50
Total raised: $151.2M
Founded date: 2012
Investors 3
Funding Rounds 4
| Date | Series | Amount | Investors |
| 11.02.2021 | Series C | $80M | - |
| 15.10.2019 | Series B | $40.2M | - |
| 08.03.2018 | Series B | $29M | - |
| 30.06.2016 | Grant | $2M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 04.06.2021 | Cyteir Therapeutics Announces Presentation of First-in-Human... | LEXINGTON, Mass., June 4, 2021 /PRNewswire/ -- Cyteir Therapeutics, a leader in the discovery and ... | prnewswire... |
| 12.02.2021 | Daily funding roundup - February 11th, 2021 | Zocdoc raised $150M; Modern Health landed $74M; Human Interest secured $55M; WireWheel picks up $20M... | vator.tv/n... |
| 11.02.2021 | Cyteir Therapeutics Secures $80 Million in Series C Financin... | LEXINGTON, Mass., Feb. 11, 2021 /PRNewswire/ -- Cyteir Therapeutics, a leader in the discovery and... | prnewswire... |
| 11.02.2021 | Cyteir Therapeutics Secures $80 Million in Series C | Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal t... | citybizlis... |
| 11.02.2021 | Cancer biotech Cyteir raises $80M, plans to double headcount... | Lexington biotech Cyteir Therapeutics, a startup whose method of fighting cancer involves an approac... | bizjournal... |
| 11.02.2021 | Cyteir adds $80M to steer to Phase 2 with lead cancer drug, ... | Lexington, Massachusetts-based Cyteir develops drugs that tap into into a genetic vulnerability of t... | medcitynew... |
| 11.02.2021 | Cancer biotech Cyteir raises $80M, plans to double headcount... | - | bizjournal... |
| 15.10.2019 | Cyteir Therapeutics Inks Additional $40.2M Series B | LEXINGTON, MA, Cyteir Therapeutics today announced the close of an additional $40.2 million in the... | vcnewsdail... |
| 15.10.2019 | Cyteir Therapeutics Raises Additional $40.2M in Series B Fin... | Cyteir Therapeutics, a Lexington, Mass.-based leader in the discovery and development of next-genera... | finsmes.co... |
| 15.10.2019 | Cyteir Therapeutics Secures Additional $40.2 Million in Its ... | Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal t... | citybizlis... |
Show more